Shareholders

Identity and percentage holding of significant shareholders

Substantial holdings	Shares held	%
Calculus Capital	3,556,782	5.62%*
Global Health Investment Fund I, LLC	2,700,000	4.27%*
Spreadex Ltd	2,123,478	3.77%* **
Directors and related shareholders
Ian Gilham	503,174	0.80%
David Budd	213,710	0.34%
Matthew Fowler	99,457	0.16%
Tom Lindsay	202,217	0.32%
Chris Yates	41,304	0.07%
Total Directors' holdings	1,059,862	1.68%

Total shares in issue	63,320,048	100.00%

* - DATE OF LAST NOTIFICATION
** - Note 494,425 of these shares are held via a CFD/Spreadbet

Shareholder information

genedrive shares are quoted and traded on the AIM market of the London Stock Exchange.

Authorised Share Capital: No authorised maximum number of shares are required. There are no shares held in treasury and there are no restrictions on transfer.

Issued Share Capital: The total number of genedrive plc ordinary shares of 1.5p each in issue is 63,320,048.

Number of AIM securities not in public hands is 12,829,644 or 22.7%.

Text updated: 28/09/2020